Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D
Pemvidutide (2.4 mg), an investigational GLP-1/glucagon dual receptor agonist, helped people with…
Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis
A real-world, preprint study in medRxiv found that people with overweight or…
Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK’d
The FDA announced a voluntary recall of an over-the-counter glucose support supplement…
One Copeptin Test More Accurate as Diagnostic for AVP Deficiency
Arginine-stimulated copeptin was inferior to hypertonic saline-stimulated copeptin in the diagnosis of…
Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes
More than one in three adults have prediabetes, representing around 98 million…
Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil?
Primary care patients with obesity were more likely to successfully lose weight…
Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer
Intermittent fasting can help patients with type 2 diabetes lose weight and…
Hospitalizations With Fake Ozempic; Vosoritide OK’d for All Ages; Mounjaro for Kids?
Law enforcement and public health officials say a surge in counterfeit versions…
Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test
Dapagliflozin (Farxiga) lowered HbA1c by 1.03 percentage points more than placebo in…
Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits
A record-breaking number of U.S. physicians applied to be certified in obesity…
